These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1765 related items for PubMed ID: 18416436
1. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research. Ekegren T, Hanrieder J, Bergquist J. J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436 [Abstract] [Full Text] [Related]
2. Focused proteomics in post-mortem human spinal cord. Ekegren T, Hanrieder J, Aquilonius SM, Bergquist J. J Proteome Res; 2006 Sep; 5(9):2364-71. PubMed ID: 16944948 [Abstract] [Full Text] [Related]
3. Identification of potential CSF biomarkers in ALS. Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, Ho L. Neurology; 2006 Apr 25; 66(8):1218-22. PubMed ID: 16481598 [Abstract] [Full Text] [Related]
4. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform. Pan S, Rush J, Peskind ER, Galasko D, Chung K, Quinn J, Jankovic J, Leverenz JB, Zabetian C, Pan C, Wang Y, Oh JH, Gao J, Zhang J, Montine T, Zhang J. J Proteome Res; 2008 Feb 25; 7(2):720-30. PubMed ID: 18186601 [Abstract] [Full Text] [Related]
5. The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences. Becker JS, Jakubowski N. Chem Soc Rev; 2009 Jul 25; 38(7):1969-83. PubMed ID: 19551177 [Abstract] [Full Text] [Related]
6. Biomarker discovery for kidney diseases by mass spectrometry. Niwa T. J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul 15; 870(2):148-53. PubMed ID: 18024247 [Abstract] [Full Text] [Related]
7. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform. Oh JH, Pan S, Zhang J, Gao J. Rapid Commun Mass Spectrom; 2010 Feb 15; 24(4):403-8. PubMed ID: 20069694 [Abstract] [Full Text] [Related]
8. Making broad proteome protein measurements in 1-5 min using high-speed RPLC separations and high-accuracy mass measurements. Shen Y, Strittmatter EF, Zhang R, Metz TO, Moore RJ, Li F, Udseth HR, Smith RD, Unger KK, Kumar D, Lubda D. Anal Chem; 2005 Dec 01; 77(23):7763-73. PubMed ID: 16316187 [Abstract] [Full Text] [Related]
9. Global and targeted quantitative proteomics for biomarker discovery. Veenstra TD. J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb 15; 847(1):3-11. PubMed ID: 17023222 [Abstract] [Full Text] [Related]
10. Comparison of indirect and direct approaches using ion-trap and Fourier transform ion cyclotron resonance mass spectrometry for exploring viperid venom proteomes. Fox JW, Ma L, Nelson K, Sherman NE, Serrano SM. Toxicon; 2006 May 15; 47(6):700-14. PubMed ID: 16574175 [Abstract] [Full Text] [Related]
11. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. Novikova SI, He F, Cutrufello NJ, Lidow MS. Neurobiol Dis; 2006 Jul 15; 23(1):61-76. PubMed ID: 16549361 [Abstract] [Full Text] [Related]
12. The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF). Rosenling T, Slim CL, Christin C, Coulier L, Shi S, Stoop MP, Bosman J, Suits F, Horvatovich PL, Stockhofe-Zurwieden N, Vreeken R, Hankemeier T, van Gool AJ, Luider TM, Bischoff R. J Proteome Res; 2009 Dec 15; 8(12):5511-22. PubMed ID: 19845411 [Abstract] [Full Text] [Related]
13. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification. Leung SM, Pitts RL. Methods Mol Biol; 2008 Dec 15; 441():57-70. PubMed ID: 18370311 [Abstract] [Full Text] [Related]
14. Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery. Krüger T, Lautenschläger J, Grosskreutz J, Rhode H. Proteomics Clin Appl; 2013 Jan 15; 7(1-2):123-35. PubMed ID: 23129563 [Abstract] [Full Text] [Related]
15. Proteomic analysis of plasma from Portuguese patients with familial amyotrophic lateral sclerosis. Palma AS, De Carvalho M, Grammel N, Pinto S, Barata N, Conradt HS, Costa J. Amyotroph Lateral Scler; 2008 Dec 15; 9(6):339-49. PubMed ID: 18608108 [Abstract] [Full Text] [Related]
16. Application of LC/MS to proteomics studies: current status and future prospects. Chen G, Pramanik BN. Drug Discov Today; 2009 May 15; 14(9-10):465-71. PubMed ID: 19429505 [Abstract] [Full Text] [Related]
17. Proteome analysis of Escherichia coli using high-performance liquid chromatography and Fourier transform ion cyclotron resonance mass spectrometry. Ihling C, Sinz A. Proteomics; 2005 May 15; 5(8):2029-42. PubMed ID: 15852340 [Abstract] [Full Text] [Related]
18. A review of current applications of mass spectrometry for neuroproteomics in epilepsy. Liu X, Wen F, Yang J, Chen L, Wei YQ. Mass Spectrom Rev; 2010 May 15; 29(2):197-246. PubMed ID: 19598206 [Abstract] [Full Text] [Related]
19. The application of proteomic techniques to fungal protein identification and quantification. Rohrbough JG, Galgiani JN, Wysocki VH. Ann N Y Acad Sci; 2007 Sep 15; 1111():133-46. PubMed ID: 17344531 [Abstract] [Full Text] [Related]
20. Miniaturized proteomics and peptidomics using capillary liquid separation and high resolution mass spectrometry. Ramström M, Bergquist J. FEBS Lett; 2004 Jun 01; 567(1):92-5. PubMed ID: 15165899 [Abstract] [Full Text] [Related] Page: [Next] [New Search]